:,

Haijun Zhang1, Xiaozhen Lai2, Bryan N Patenaude3

  • 1Department of Health Policy and Management, School of Public Health, Peking University, Beijing, China; International Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Department of Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.

The Lancet. Public health
|November 24, 2023
PubMed
概括

将四种关键的儿童疫苗引入中国的国家免疫计划可以防止数千人死亡. 肺炎球菌合疫苗 (PCV13) 提供了最重要的影响,其次是轮状病毒,Hib和水疫苗.